iBio Inc (IBIO)
1.72
-0.18
(-9.47%)
USD |
NYAM |
Apr 25, 16:00
1.69
-0.03
(-1.74%)
After-Hours: 20:00
iBio Free Cash Flow: -18.89M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.89M |
| September 30, 2023 | -21.82M |
| June 30, 2023 | -36.17M |
| March 31, 2023 | -45.63M |
| December 31, 2022 | -49.98M |
| September 30, 2022 | -52.21M |
| June 30, 2022 | -49.11M |
| March 31, 2022 | -43.96M |
| December 31, 2021 | -44.30M |
| September 30, 2021 | -40.91M |
| June 30, 2021 | -35.23M |
| March 31, 2021 | -30.13M |
| December 31, 2020 | -25.65M |
| September 30, 2020 | -19.84M |
| June 30, 2020 | -14.50M |
| March 31, 2020 | -14.38M |
| December 31, 2019 | -14.77M |
| September 30, 2019 | -16.22M |
| June 30, 2019 | -14.96M |
| March 31, 2019 | -14.06M |
| December 31, 2018 | -13.77M |
| September 30, 2018 | -12.50M |
| June 30, 2018 | -14.56M |
| March 31, 2018 | -15.19M |
| December 31, 2017 | -15.07M |
| Date | Value |
|---|---|
| September 30, 2017 | -15.01M |
| June 30, 2017 | -14.76M |
| March 31, 2017 | -13.35M |
| December 31, 2016 | -11.92M |
| September 30, 2016 | -9.85M |
| June 30, 2016 | -8.14M |
| March 31, 2016 | -6.528M |
| December 31, 2015 | -5.466M |
| September 30, 2015 | -5.504M |
| June 30, 2015 | -4.94M |
| March 31, 2015 | -4.413M |
| December 31, 2014 | -4.381M |
| September 30, 2014 | -4.006M |
| June 30, 2014 | -4.375M |
| March 31, 2014 | -4.578M |
| December 31, 2013 | -4.526M |
| September 30, 2013 | -4.666M |
| June 30, 2013 | -5.044M |
| March 31, 2013 | -5.198M |
| December 31, 2012 | -6.926M |
| September 30, 2012 | -6.282M |
| June 30, 2012 | -6.255M |
| March 31, 2012 | -6.148M |
| December 31, 2011 | -5.19M |
| September 30, 2011 | -6.157M |
Free Cash Flow Range, Past 5 Years
-52.21M
Minimum
Sep 2022
-14.38M
Maximum
Mar 2020
-30.98M
Average
-30.13M
Median
Mar 2021
Free Cash Flow Benchmarks
| Lixte Biotechnology Holdings Inc | -4.293M |
| PAVmed Inc | -52.28M |
| Avalo Therapeutics Inc | -30.68M |
| Imunon Inc | -19.47M |
| Ocugen Inc | -72.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.706M |
| Cash from Financing (Quarterly) | 4.005M |
| Free Cash Flow Per Share (Quarterly) | -2.536 |
| Free Cash Flow Yield | -977.4% |